The main objective of this EAP is to ensure that participants participating in Study
E2007-G000-332, Study E2007-G000-311, E2007-G000-238, E2007-G000-338 or EAP E2007-G000-401
continue to have access to perampanel until such time that the appropriate formulation of
perampanel becomes commercially available in the country in which they reside or until no
participants remain in the EAP.